Subjects: H.R.1727 — 105th Congress (1997-1998)

  • Child health
  • Clinical trials
  • Commerce
  • Congress
  • Congressional reporting requirements
  • Drug approvals
  • Drug industry
  • Economic impact statements
  • Economics and Public Finance
  • Families
  • Government Operations and Politics
  • Government paperwork
  • Government publicity
  • Health
  • Medical research
  • Pharmaceutical research
  • Science, Technology, Communications